Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity (original) (raw)

1. Yang YS, Han BD, Han K, Jung JH, Son JW; Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity. Obesity fact sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019. J Obes Metab Syndr 2022;31:169-77.
   
2. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009;9:88.
   
3. Schienkiewitz A, Mensink GB, Scheidt-Nave C. Comorbidity of overweight and obesity in a nationally representative sample of German adults aged 18-79 years. BMC Public Health 2012;12:658.
   
4. Haase CL, Lopes S, Olsen AH, Satylganova A, Schnecke V, McEwan P. Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database. Int J Obes (Lond) 2021;45:1249-58.
   
5. Thavorncharoensap M. ADBI Working Paper 654: Effectiveness of obesity prevention and control [Internet]. SSRN; 2017 [cited 2023 Mar 21]. Available from: http://dx.doi.org/10.2139/ssrn.3016129.
   
6. Korean Ministry of Health & Welfare, Korean Academy of Medical Sciences. Adaptation process for developing Korean clinical practice guidelines. KAMS; 2011.
7. Schünemann HJ, Wiercioch W, Brozek J, Etxeandia-Ikobaltzeta I, Mustafa RA, Manja V, et al. GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT. J Clin Epidemiol 2017;81:101-10.
   
8. Graf CE, Herrmann FR, Spoerri A, Makhlouf AM, Sørensen TI, Ho S, et al. Impact of body composition changes on risk of all-cause mortality in older adults. Clin Nutr 2016;35:1499-505.
   
9. Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V, et al. Health consequences of obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond) 2005;29:1011-29.
   
10. Zaslavsky O, Rillamas-Sun E, LaCroix AZ, Woods NF, Tinker LF, Zisberg A, et al. Association between anthropometric measures and long-term survival in frail older women: observations from the women's health initiative study. J Am Geriatr Soc 2016;64:277-84.
    
11. Committee of Childhood and Adolescence of the Korean Society for the Study of Obesity. Obesity in children and adolescents. 3rd ed. The Korean Society for the Study of Obesity; 2019.
12. Kim BY, Kang SM, Kang JH, Kang SY, Kim KK, Kim KB, et al. 2020 Korean Society for the Study of Obesity guidelines for the management of obesity in Korea. J Obes Metab Syndr 2021;30:81-92.
    
13. Kelly AS, Barlow SE, Rao G, Inge TH, Hayman LL, Steinberger J, et al. Severe obesity in children and adolescents: identification, associated health risks, and treatment approaches: a scientific statement from the American Heart Association. Circulation 2013;128:1689-712.
    
14. US Preventive Services Task Force; Grossman DC, Bibbins-Domingo K, Curry SJ, Barry MJ, Davidson KW, et al. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA 2017; 317:2417-26.
    
15. Bays HE, Chapman RH, Grandy S; SHIELD Investigators' Group. The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 2007;61:737-47.
    
16. Goodarzi MO. Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications. Lancet Diabetes Endocrinol 2018;6:223-36.
    
17. Qasim A, Turcotte M, de Souza RJ, Samaan MC, Champredon D, Dushoff J, et al. On the origin of obesity: identifying the biological, environmental and cultural drivers of genetic risk among human populations. Obes Rev 2018;19:121-49.
    
18. Lyznicki JM, Young DC, Riggs JA, Davis RM; Council on Scientific Affairs, American Medical Association. Obesity: assessment and management in primary care. Am Fam Physician 2001;63:2185-96.
19. Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M, et al. The science of obesity management: an endocrine society scientific statement. Endocr Rev 2018;39:79-132.
    
20. US Preventive Services Task Force; Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. JAMA 2018;320:1163-71.
    
21. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract 2016;22 Suppl 3:1-203.
    
22. Sanchez-Santos MT, Judge A, Gulati M, Spector TD, Hart DJ, Newton JL, et al. Association of metabolic syndrome with knee and hand osteoarthritis: a community-based study of women. Semin Arthritis Rheum 2019;48:791-8.
    
23. Xie L, Chen Y, Tan A, Gao Y, Yang X, Mo Z, et al. Central obesity indicating a higher prevalence of lower urinary tract symptoms: a case-control matching analysis from a Chinese cross-sectional study in males. Low Urin Tract Symptoms 2019;11:O135-40.
    
24. Russell T, Duntley S. Sleep disordered breathing in the elderly. Am J Med 2011;124:1123-6.
    
25. Lim S, Kwon SY, Yoon JW, Kim SY, Choi SH, Park YJ, et al. Association between body composition and pulmonary function in elderly people: the Korean Longitudinal Study on Health and Aging. Obesity (Silver Spring) 2011;19:631-8.
    
26. Arnold M, Freisling H, Stolzenberg-Solomon R, Kee F, O'Doherty MG, Ordóñez-Mena JM, et al. Overweight duration in older adults and cancer risk: a study of cohorts in Europe and the United States. Eur J Epidemiol 2016;31:893-904.
    
27. Lee KR, Hwang IC, Han KD, Jung J, Seo MH. Waist circumference and risk of breast cancer in Korean women: a nationwide cohort study. Int J Cancer 2018;142:1554-9.
    
28. Yoo S, Oh S, Park J, Cho SY, Cho MC, Son H, et al. Effects of metabolic syndrome on the prevalence of prostate cancer: historical cohort study using the National Health Insurance Service Database. J Cancer Res Clin Oncol 2019;145:775-80.
    
29. Villareal DT, Apovian CM, Kushner RF, Klein S; American Society for Nutrition; NAASO, The Obesity Society. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr 2005;82:923-34.
    
30. Park S, Joo YH, McIntyre RS, Kim B. Metabolic syndrome and elevated C-reactive protein levels in elderly patients with newly diagnosed depression. Psychosomatics 2014;55:640-9.
    
31. Danat IM, Clifford A, Partridge M, Zhou W, Bakre AT, Chen A, et al. Impacts of overweight and obesity in older age on the risk of dementia: a systematic literature review and a meta-analysis. J Alzheimers Dis 2019;70(s1):S87-99.
    
32. Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, et al. Bodymass index and mortality in Korean men and women. N Engl J Med 2006;355:779-87.
    
33. Amiri S, Behnezhad S, Hasani J. Body mass index and risk of frailty in older adults: a systematic review and meta-analysis. Obesity Medicine 2020;18:100196.
    
34. Neri SG, Oliveira JS, Dario AB, Lima RM, Tiedemann A. Does obesity increase the risk and severity of falls in people aged 60 years and older? A systematic review and meta-analysis of observational studies. J Gerontol A Biol Sci Med Sci 2020;75:952-60.
    
35. Seimon RV, Wild-Taylor AL, Keating SE, McClintock S, Harper C, Gibson AA, et al. Effect of weight loss via severe vs moderate energy restriction on lean mass and body composition among postmenopausal women with obesity: the TEMPO diet randomized clinical trial. JAMA Netw Open 2019;2:e1913733.
    
36. Kim S, Kim M, Won CW. Validation of the Korean version of the SARC-F Questionnaire to assess sarcopenia: Korean Frailty and Aging Cohort Study. J Am Med Dir Assoc 2018;19:40-5.e1.
    
37. Zhang X, Xie X, Dou Q, Liu C, Zhang W, Yang Y, et al. Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: a updated meta-analysis. BMC Geriatr 2019;19:183.
    
38. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014;129(25 Suppl 2):S102-38.
    
39. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, et al. European guidelines for obesity management in adults. Obes Facts 2015;8:402-24.
    
40. Wharton S, Lau DC, Vallis M, Sharma AM, Biertho L, Campbell-Scherer D, et al. Obesity in adults: a clinical practice guideline. CMAJ 2020;192:E875-91.
    
41. Bays JC. Mindful eating: a guide to rediscovering a healthy and joyful relationship with food. Shambhala; 2009.
42. Alberts HJ, Thewissen R, Raes L. Dealing with problematic eating behaviour: the effects of a mindfulness-based intervention on eating behaviour, food cravings, dichotomous thinking and body image concern. Appetite 2012;58:847-51.
    
43. Mason AE, Lustig RH, Brown RR, Acree M, Bacchetti P, Moran PJ, et al. Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial. Appetite 2015;91:311-20.
    
44. Rogers JM, Ferrari M, Mosely K, Lang CP, Brennan L. Mindfulness-based interventions for adults who are overweight or obese: a meta-analysis of physical and psychological health outcomes. Obes Rev 2017;18:51-67.
    
45. Braden A, Ferrell E, Anderson LN, Grant J, Watford T, Barnhart W. Adapted dialectical behavioral therapy for overweight/obese emotional eaters. Obesity 2020;28:46.
46. Chung YL, Rhie YJ. Severe obesity in children and adolescents: metabolic effects, assessment, and treatment. J Obes Metab Syndr 2021;30:326-35.
    
47. Haskins IN, Amdur R, Vaziri K. The effect of smoking on bariatric surgical outcomes. Surg Endosc 2014;28:3074-80.
    
48. Di Lorenzo N, Antoniou SA, Batterham RL, Busetto L, Godoroja D, Iossa A, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc 2020;34:2332-58.
    
49. Rudolph A, Hilbert A. Post-operative behavioural management in bariatric surgery: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 2013;14:292-302.
    
50. Stewart F, Avenell A. Behavioural interventions for severe obesity before and/or after bariatric surgery: a systematic review and meta-analysis. Obes Surg 2016;26:1203-14.
    
51. Li Z, Zhou X, Fu W. Vitamin D supplementation for the prevention of vitamin D deficiency after bariatric surgery: a systematic review and meta-analysis. Eur J Clin Nutr 2018;72:1061-70.
    
52. Styne DM, Arslanian SA, Connor EL, Farooqi IS, Murad MH, Silverstein JH, et al. Pediatric obesity-assessment, treatment, and prevention: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2017;102:709-57.
    
53. Bolling CF, Armstrong SC, Reichard KW, Michalsky MP; Section on Obesity, Section on Surgery. Metabolic and bariatric surgery for pediatric patients with severe obesity. Pediatrics 2019;144:e20193224.
    
54. Armstrong SC, Bolling CF, Michalsky MP, Reichard KW; Section on Obesity, Section on Surgery. Pediatric metabolic and bariatric surgery: evidence, barriers, and best practices. Pediatrics 2019;144:e20193223.
    
55. Pratt JS, Browne A, Browne NT, Bruzoni M, Cohen M, Desai A, et al. ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis 2018;14:882-901.
    
56. Nabuco HC, Tomeleri CM, Fernandes RR, Sugihara Junior P, Cavalcante EF, Cunha PM, et al. Effect of whey protein supplementation combined with resistance training on body composition, muscular strength, functional capacity, and plasma-metabolism biomarkers in older women with sarcopenic obesity: a randomized, double-blind, placebo-controlled trial. Clin Nutr ESPEN 2019;32:88-95.
    
57. Han TS, Wu FC, Lean ME. Obesity and weight management in the elderly: a focus on men. Best Pract Res Clin Endocrinol Metab 2013;27:509-25.
    
58. Daigle CR, Andalib A, Corcelles R, Cetin D, Schauer PR, Brethauer SA. Bariatric and metabolic outcomes in the super-obese elderly. Surg Obes Relat Dis 2016;12:132-7.
    
59. Haywood C, Sumithran P. Treatment of obesity in older persons: a systematic review. Obes Rev 2019;20:588-98.
    
60. Heymsfield SB, Peterson CM, Thomas DM, Heo M, Schuna JM, Hong S, et al. Scaling of adult body weight to height across sex and race/ethnic groups: relevance to BMI. Am J Clin Nutr 2014;100:1455-61.
    
61. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. WHO; 2000.
62. Seo MH, Kim YH, Han K, Lee WY, Yoo SJ. Prevalence of obesity and incidence of obesity-related comorbidities in Koreans based on National Health Insurance Service Health Checkup Data 2006-2015 (J Obes Metab Syndr 2018;27: 46-52). J Obes Metab Syndr 2018;27:198-9.
    
63. Tobias DK, Pan A, Jackson CL, O'Reilly EJ, Ding EL, Willett WC, et al. Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med 2014;370:233-44.
    
64. Twig G, Afek A, Derazne E, Tzur D, Cukierman-Yaffe T, Gerstein HC, et al. Diabetes risk among overweight and obese metabolically healthy young adults. Diabetes Care 2014;37:2989-95.
    
65. Abdullah A, Peeters A, de Courten M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Res Clin Pract 2010;89:309-19.
    
66. Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2006;84:427-33.
    
67. Strazzullo P, D'Elia L, Cairella G, Garbagnati F, Cappuccio FP, Scalfi L. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke 2010;41:e418-26.
    
68. Rea TD, Heckbert SR, Kaplan RC, Psaty BM, Smith NL, Lemaitre RN, et al. Body mass index and the risk of recurrent coronary events following acute myocardial infarction. Am J Cardiol 2001;88:467-72.
    
69. Prospective Studies Collaboration; Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009;373:1083-96.
    
70. Lee SY, Park HS, Kim DJ, Han JH, Kim SM, Cho GJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75:72-80.
    
71. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 2014;63(25 Pt B):2985-3023.
    
72. Muscogiuri G, El Ghoch M, Colao A, Hassapidou M, Yumuk V, Busetto L, et al. European guidelines for obesity management in adults with a very low-calorie ketogenic diet: a systematic review and meta-analysis. Obes Facts 2021;14:222-45.
    
73. American College of Sports Medicine. ACSM’s exercise testing and prescription. 11th ed. Wolter Kluwer; 2021.
74. Go G. Physical activity status and task. Health Welf Policy Forum 2013;198:38-47.
75. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK, et al. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009;41:459-71.
    
76. Kim KB, Kim K, Kim C, Kang SJ, Kim HJ, Yoon S, et al. Effects of exercise on the body composition and lipid profile of individuals with obesity: a systematic review and metaanalysis. J Obes Metab Syndr 2019;28:278-94.
    
77. González-Nóvoa JA, Campanioni S, Busto L, Fariña J, Rodríguez-Andina JJ, Vila D, et al. Improving intensive care unit early readmission prediction using optimized and explainable machine learning. Int J Environ Res Public Health 2023;20:3455.
    
78. Liguori G; American College of Sports Medicine. ACSM's guidelines for exercise testing and prescription. 10th ed. Lippincott Williams & Wilkins; 2020.
79. Morze J, Rücker G, Danielewicz A, Przybyłowicz K, Neuenschwander M, Schlesinger S, et al. Impact of different training modalities on anthropometric outcomes in patients with obesity: a systematic review and network meta-analysis. Obes Rev 2021;22:e13218.
    
80. Oppert JM, Bellicha A, van Baak MA, Battista F, Beaulieu K, Blundell JE, et al. Exercise training in the management of overweight and obesity in adults: synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group. Obes Rev 2021;22 Suppl 4:e13273.
    
81. Thorogood A, Mottillo S, Shimony A, Filion KB, Joseph L, Genest J, et al. Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials. Am J Med 2011;124:747-55.
    
82. Schwingshackl L, Dias S, Strasser B, Hoffmann G. Impact of different training modalities on anthropometric and metabolic characteristics in overweight/obese subjects: a systematic review and network meta-analysis. PLoS One 2013;8:e82853.
    
83. Washburn RA, Szabo AN, Lambourne K, Willis EA, Ptomey LT, Honas JJ, et al. Does the method of weight loss effect long-term changes in weight, body composition or chronic disease risk factors in overweight or obese adults? A systematic review. PLoS One 2014;9:e109849.
    
84. Hamman RF, Wing RR, Edelstein SL, Lachin JM, Bray GA, Delahanty L, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006;29:2102-7.
    
85. Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring) 2014;22:5-13.
    
86. American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel, 2013. Expert Panel Report: Guidelines (2013) for the management of overweight and obesity in adults. Obesity (Silver Spring) 2014;22 Suppl 2:S41-410.
    
87. Svetkey LP, Stevens VJ, Brantley PJ, Appel LJ, Hollis JF, Loria CM, et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 2008;299:1139-48.
    
88. Look AHEAD Research Group; Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: fouryear results of the Look AHEAD trial. Arch Intern Med 2010; 170:1566-75.
    
89. Perri MG, Nezu AM, McKelvey WF, Shermer RL, Renjilian DA, Viegener BJ. Relapse prevention training and problemsolving therapy in the long-term management of obesity. J Consult Clin Psychol 2001;69:722-6.
    
90. Lv N, Azar KM, Rosas LG, Wulfovich S, Xiao L, Ma J. Behavioral lifestyle interventions for moderate and severe obesity: a systematic review. Prev Med 2017;100:180-93.
    
91. Carels RA, Darby L, Cacciapaglia HM, Douglass OM, Harper J, Kaplar ME, et al. Applying a stepped-care approach to the treatment of obesity. J Psychosom Res 2005;59:375-83.
    
92. Miller CK, Nagaraja HN, Weinhold KR. Early weight-loss success identifies nonresponders after a lifestyle intervention in a worksite diabetes prevention trial. J Acad Nutr Diet 2015;115:1464-71.
    
93. Golzarand M, Salari-Moghaddam A, Mirmiran P. Association between alcohol intake and overweight and obesity: a systematic review and dose-response meta-analysis of 127 observational studies. Crit Rev Food Sci Nutr 2022;62:8078-98.
    
94. Choi S, Kim K, Lee JK, Choi JY, Shin A, Park SK, et al. Association between change in alcohol consumption and metabolic syndrome: analysis from the health examinees study. Diabetes Metab J 2019;43:615-26.
    
95. Chao AM, Wadden TA, Tronieri JS, Berkowitz RI. Alcohol intake and weight loss during intensive lifestyle intervention for adults with overweight or obesity and diabetes. Obesity (Silver Spring) 2019;27:30-40.
    
96. Bush T, Lovejoy JC, Deprey M, Carpenter KM. The effect of tobacco cessation on weight gain, obesity, and diabetes risk. Obesity (Silver Spring) 2016;24:1834-41.
    
97. Farley AC, Hajek P, Lycett D, Aveyard P. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev 2012;1:CD006219.
    
98. Ussher MH, Taylor A, Faulkner G. Exercise interventions for smoking cessation. Cochrane Database Syst Rev 2012;1:CD002295.
    
99. Sjöström L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar HP, et al. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998;352:167-72.
    
100. Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med 2001;161:218-27.
     
101. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004;27:155-61.
     
102. Wadden TA, Berkowitz RI, Womble LG, Sarwer DB, Phelan S, Cato RK, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005;353:2111-20.
     
103. Poston WS, Haddock CK, Pinkston MM, Pace P, Reeves RS, Karakoc N, et al. Evaluation of a primary care-oriented brief counselling intervention for obesity with and without orlistat. J Intern Med 2006;260:388-98.
     
104. Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (CORI): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2010;376:595-605.
     
105. Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O'Neil PM, et al. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring) 2011;19:110-20.
     
106. Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring) 2012;20:330-42.
     
107. Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr 2012;95:297-308.
     
108. Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, et al. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring) 2013;21:935-43.
     
109. Hollander P, Gupta AK, Plodkowski R, Greenway F, Bays H, Burns C, et al. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care 2013;36:4022-9.
     
110. Garvey WT, Ryan DH, Henry R, Bohannon NJ, Toplak H, Schwiers M, et al. Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release. Diabetes Care 2014;37:912-21.
     
111. Davies MJ, Bergenstal R, Bode B, Kushner RF, Lewin A, Skjøth TV, et al. Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial. JAMA 2015;314:687-99.
     
112. Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med 2015;373:11-22.
     
113. North American Association for the Study of Obesity, National Heart, Lung, and Blood Institute, National Institutes of Health (U.S.), NHLBI Obesity Education Initiative. The practical guide: identification, evaluation, and treatment of overweight and obesity in adults. National Heart, Lung, and Blood Institute; 2000.
114. Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med 2010;363:245-56.
     
115. Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, et al. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance. Diabetes Obes Metab 2005;7:699-708.
     
116. Finer N, Ryan DH, Renz CL, Hewkin AC. Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients. Diabetes Obes Metab 2006;8:206-13.
     
117. Rissanen A, Lean M, Rössner S, Segal KR, Sjöström L. Predictive value of early weight loss in obesity management with orlistat: an evidence-based assessment of prescribing guidelines. Int J Obes Relat Metab Disord 2003;27:103-9.
     
118. Alonso-Troncoso I, Carollo-Limeres C, Rios-Prego M, Guler I, Cadarso-Suárez C, F-Mariño A. Liraglutide in a real-world setting: joint modeling of metabolic response, prediction of efficacy, and cardiovascular risk. Endocrinol Diabetes Nutr (Engl Ed) 2019;66:376-84.
     
119. Fujioka K, Plodkowski R, O'Neil PM, Gilder K, Walsh B, Greenway FL. The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy. Int J Obes (Lond) 2016;40:1369-75.
     
120. Fujioka K, O'Neil PM, Davies M, Greenway F, Lau DC, Claudius B, et al. Early weight loss with liraglutide 3.0 mg predicts 1-year weight loss and is associated with improvements in clinical markers. Obesity (Silver Spring) 2016;24:2278-88.
     
121. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric surgery versus intensive medical therapy for diabetes: 5-year outcomes. N Engl J Med 2017;376:641-51.
     
122. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2015;386:964-73.
     
123. Bennett S, Gostimir M, Shorr R, Mallick R, Mamazza J, Neville A. The role of routine preoperative upper endoscopy in bariatric surgery: a systematic review and meta-analysis. Surg Obes Relat Dis 2016;12:1116-25.
     
124. Sauerland S, Angrisani L, Belachew M, Chevallier JM, Favretti F, Finer N, et al. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2005;19:200-21.
     
125. Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Goisser S, Hooper L, et al. ESPEN guideline on clinical nutrition and hydration in geriatrics. Clin Nutr 2019;38:10-47.
     
126. Venditti EM, Marcus MD, Miller RG, Arena VC, Greenspan SL, Rockette-Wagner B. Group lifestyle phone maintenance for weight, health, and physical function in adults aged 65-80 years: a randomized clinical trial. J Gerontol A Biol Sci Med Sci 2021;76:352-60.
     
127. Dong F, Zhang Y, Huang Y, Wang Y, Zhang G, Hu X, et al. Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial. Sci Rep 2016;6:36783.
     
128. Ballin M, Lundberg E, Sörlén N, Nordström P, Hult A, Nordström A. Effects of interval training on visceral adipose tissue in centrally obese 70-year-old individuals: a randomized controlled trial. J Am Geriatr Soc 2019;67:1625-31.
     
129. Giordano S, Victorzon M. Bariatric surgery in elderly patients: a systematic review. Clin Interv Aging 2015;10:1627-35.
     
130. Committee of Childhood and Adolescence of the Korean Society for the Study of Obesity. Obesity in children and adolescents. 3rd ed. The Korean Society for the Study of Obesity; 2019.
131. The Korean Centers for Disease Control and Prevention, The Korean Pediatric Society. 2017 Korean national growth chart for children and adolescents. KCDC; 2017.
132. Korean Society of Pediatric Endocrinology. Pediatric endocrinology. 3rd ed. Gunja Publishing Co.; 2014.
133. Barlow SE; Expert Committee. Expert Committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics 2007;120 Suppl 4:S164-92.
     
134. Speiser PW, Rudolf MC, Anhalt H, Camacho-Hubner C, Chiarelli F, Eliakim A, et al. Childhood obesity. J Clin Endocrinol Metab 2005;90:1871-87.
     
135. Zwiauer KF. Prevention and treatment of overweight and obesity in children and adolescents. Eur J Pediatr 2000;159 Suppl 1:S56-68.
     
136. Seo YG, Lim H, Kim Y, Ju YS, Lee HJ, Jang HB, et al. The effect of a multidisciplinary lifestyle intervention on obesity status, body composition, physical fitness, and cardiometabolic risk markers in children and adolescents with obesity. Nutrients 2019;11:137.
     
137. Ovesen P, Rasmussen S, Kesmodel U. Effect of prepregnancy maternal overweight and obesity on pregnancy outcome. Obstet Gynecol 2011;118(2 Pt 1):305-12.
     
138. Schummers L, Hutcheon JA, Bodnar LM, Lieberman E, Himes KP. Risk of adverse pregnancy outcomes by prepregnancy body mass index: a population-based study to inform prepregnancy weight loss counseling. Obstet Gynecol 2015;125:133-43.
     
139. Doherty DA, Magann EF, Francis J, Morrison JC, Newnham JP. Pre-pregnancy body mass index and pregnancy outcomes. Int J Gynaecol Obstet 2006;95:242-7.
     
140. Lim J, Han K, Kim SY, Cho YH, Yoon YS, Park HS, et al. Effects of central obesity on maternal complications in Korean women of reproductive age. Obes Res Clin Pract 2019;13:156-63.
     
141. Kim BY, Kim B, Han K, Chon SJ, Yoo SJ, Kim KK, et al. Pre-pregnancy metabolic syndrome and insulin administration in gestational diabetes: a nationwide population-based cohort study. Obes Res Clin Pract 2021;15:362-7.
     
142. Boots C, Stephenson MD. Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review. Semin Reprod Med 2011;29:507-13.
     
143. Zhou Y, Li H, Zhang Y, Zhang L, Liu J, Liu J. Association of maternal obesity in early pregnancy with adverse pregnancy outcomes: a Chinese prospective cohort analysis. Obesity (Silver Spring) 2019;27:1030-6.
     
144. Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity's impact. Fertil Steril 2017;107:840-7.
     
145. Luke B, Brown MB, Missmer SA, Bukulmez O, Leach R, Stern JE, et al. The effect of increasing obesity on the response to and outcome of assisted reproductive technology: a national study. Fertil Steril 2011;96:820-5.
     
146. National Institute for Health and Care Excellence. Weight management before, during and after pregnancy. NICE; 2010.
147. Magro-Malosso ER, Saccone G, Di Mascio D, Di Tommaso M, Berghella V. Exercise during pregnancy and risk of preterm birth in overweight and obese women: a systematic review and meta-analysis of randomized controlled trials. Acta Obstet Gynecol Scand 2017;96:263-73.
     
148. Piccinini-Vallis H, Adamo K, Bell R, Pereira L, Nerenberg K. Canadian Adult Obesity Clinical Practice Guidelines: Weight management over the reproductive years for adult women living with obesity [Internet]. ASOI; 2020 [cited 2023 Mar 21]. Available from: https://asoi.info/wp-content/uploads/2022/10/18_IR_WeightManagementReproductiveYears-FINAL.pdf.
149. Goldstein RF, Abell SK, Ranasinha S, Misso M, Boyle JA, Black MH, et al. Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis. JAMA 2017;317:2207-25.
     
150. Streuling I, Beyerlein A, von Kries R. Can gestational weight gain be modified by increasing physical activity and diet counseling? A meta-analysis of interventional trials. Am J Clin Nutr 2010;92:678-87.
     
151. Nascimento SL, Pudwell J, Surita FG, Adamo KB, Smith GN. The effect of physical exercise strategies on weight loss in postpartum women: a systematic review and meta-analysis. Int J Obes (Lond) 2014;38:626-35.
     
152. Greendale GA, Sternfeld B, Huang M, Han W, Karvonen-Gutierrez C, Ruppert K, et al. Changes in body composition and weight during the menopause transition. JCI Insight 2019;4:e124865.
     
153. Ambikairajah A, Walsh E, Tabatabaei-Jafari H, Cherbuin N. Fat mass changes during menopause: a metaanalysis. Am J Obstet Gynecol 2019;221:393-409.e50.
     
154. Leeners B, Geary N, Tobler PN, Asarian L. Ovarian hormones and obesity. Hum Reprod Update 2017;23:300-21.
     
155. Arner P, Lithell H, Wahrenberg H, Brönnegard M. Expression of lipoprotein lipase in different human subcutaneous adipose tissue regions. J Lipid Res 1991;32:423-9.
     
156. Lovejoy JC, Champagne CM, de Jonge L, Xie H, Smith SR. Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) 2008;32:949-58.
     
157. Kozakowski J, Gietka-Czernel M, Leszczyńska D, Majos A. Obesity in menopause: our negligence or an unfortunate inevitability? Prz Menopauzalny 2017;16:61-5.
     
158. Zamboni M, Armellini F, Milani MP, De Marchi M, Todesco T, Robbi R, et al. Body fat distribution in pre- and postmenopausal women: metabolic and anthropometric variables and their inter-relationships. Int J Obes Relat Metab Disord 1992;16:495-504.
159. Norman RJ, Flight IH, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database Syst Rev 2000;2:CD001018.
160. Bonfioli E, Berti L, Goss C, Muraro F, Burti L. Health promotion lifestyle interventions for weight management in psychosis: a systematic review and meta-analysis of randomised controlled trials. BMC Psychiatry 2012;12:78.
     
161. Mugisha J, De Hert M, Stubbs B, Basangwa D, Vancampfort D. Physical health policies and metabolic screening in mental health care systems of sub-Saharan African countries: a systematic review. Int J Ment Health Syst 2017;11:31.
     
162. Hardy S, Hinks P, Gray R. Screening for cardiovascular risk in patients with severe mental illness in primary care: a comparison with patients with diabetes. J Ment Health 2013;22:42-50.
     
163. Mangurian C, Newcomer JW, Modlin C, Schillinger D. Diabetes and cardiovascular care among people with severe mental illness: a literature review. J Gen Intern Med 2016;31:1083-91.
     
164. Singh VK, Karmani S, Malo PK, Virupaksha HG, Muralidhar D, Venkatasubramanian G, et al. Impact of lifestyle modification on some components of metabolic syndrome in persons with severe mental disorders: a meta-analysis. Schizophr Res 2018;202:17-25.
     
165. Naslund JA, Whiteman KL, McHugo GJ, Aschbrenner KA, Marsch LA, Bartels SJ. Lifestyle interventions for weight loss among overweight and obese adults with serious mental illness: a systematic review and meta-analysis. Gen Hosp Psychiatry 2017;47:83-102.
     
166. Speyer H, Jakobsen AS, Westergaard C, Nørgaard HC, Jørgensen KB, Pisinger C, et al. Lifestyle interventions for weight management in people with serious mental illness: a systematic review with meta-analysis, trial sequential analysis, and meta-regression analysis exploring the mediators and moderators of treatment effects. Psychother Psychosom 2019;88:350-62.
     
167. Palavras MA, Hay P, Filho CA, Claudino A. The efficacy of psychological therapies in reducing weight and binge eating in people with bulimia nervosa and binge eating disorder who are overweight or obese: a critical synthesis and metaanalyses. Nutrients 2017;9:299.
     
168. Grilo CM, Lydecker JA, Morgan PT, Gueorguieva R. Naltrexone + bupropion combination for the treatment of binge-eating disorder with obesity: a randomized, controlled pilot study. Clin Ther 2021;43:112-22.e1.
     
169. Anandam A, Akinnusi M, Kufel T, Porhomayon J, El-Solh AA. Effects of dietary weight loss on obstructive sleep apnea: a meta-analysis. Sleep Breath 2013;17:227-34.
     
170. Thomasouli MA, Brady EM, Davies MJ, Hall AP, Khunti K, Morris DH, et al. The impact of diet and lifestyle management strategies for obstructive sleep apnoea in adults: a systematic review and meta-analysis of randomised controlled trials. Sleep Breath 2013;17:925-35.
     
171. Araghi MH, Chen YF, Jagielski A, Choudhury S, Banerjee D, Hussain S, et al. Effectiveness of lifestyle interventions on obstructive sleep apnea (OSA): systematic review and metaanalysis. Sleep 2013;36:1553-62.
     
172. Mitchell LJ, Davidson ZE, Bonham M, O'Driscoll DM, Hamilton GS, Truby H. Weight loss from lifestyle interventions and severity of sleep apnoea: a systematic review and metaanalysis. Sleep Med 2014;15:1173-83.
     
173. Carneiro-Barrera A, Díaz-Román A, Guillén-Riquelme A, Buela-Casal G. Weight loss and lifestyle interventions for obstructive sleep apnoea in adults: systematic review and meta-analysis. Obes Rev 2019;20:750-62.
     
174. Lins-Filho O, Porto Aguiar JL, Vieira de Almeida JR, Soares AH, Ritti-Dias R, Julia da Silva M, et al. Effect of exercise training on body composition in patients with obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med 2021;87:105-13.
     
175. Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol 2015;3:866-75.
     
176. Merlotti C, Morabito A, Ceriani V, Pontiroli AE. Prevention of type 2 diabetes in obese at-risk subjects: a systematic review and meta-analysis. Acta Diabetol 2014;51:853-63.
     
177. Clamp LD, Hume DJ, Lambert EV, Kroff J. Enhanced insulin sensitivity in successful, long-term weight loss maintainers compared with matched controls with no weight loss history. Nutr Diabetes 2017;7:e282.
     
178. Kuna ST, Reboussin DM, Strotmeyer ES, Millman RP, Zammit G, Walkup MP, et al. Effects of weight loss on obstructive sleep apnea severity: ten-year results of the Sleep AHEAD study. Am J Respir Crit Care Med 2021;203:221-9.
     
179. Romero-Gómez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol 2017;67:829-46.
     
180. Bliddal H, Leeds AR, Stigsgaard L, Astrup A, Christensen R. Weight loss as treatment for knee osteoarthritis symptoms in obese patients: 1-year results from a randomised controlled trial. Ann Rheum Dis 2011;70:1798-803.
     
181. Espeland MA, Luchsinger JA, Neiberg RH, Carmichael O, Laurienti PJ, Pi-Sunyer X, et al. Long term effect of intensive lifestyle intervention on cerebral blood flow. J Am Geriatr Soc 2018;66:120-6.
     
182. Espeland MA, Carmichael O, Hayden K, Neiberg RH, Newman AB, Keller JN, et al. Long-term impact of weight loss intervention on changes in cognitive function: exploratory analyses from the action for health in diabetes randomized controlled clinical trial. J Gerontol A Biol Sci Med Sci 2018;73:484-91.
     
183. Espeland MA, Erickson K, Neiberg RH, Jakicic JM, Wadden TA, Wing RR, et al. Brain and white matter hyperintensity volumes after 10 years of random assignment to lifestyle intervention. Diabetes Care 2016;39:764-71.
     
184. Gepner Y, Goldstein N, Shelef I, Schwarzfuchs D, Zelicha H, Meir AY, et al. Dissociation between long-term weight loss intervention and blood pressure: an 18-month randomized controlled trial. J Gen Intern Med 2021;36:2300-6.
     
185. Shariaty S, Bahonaran A, Ayremlou P, Hoseinalizdeh L, Alizadeh M. Comparison of dietary patterns, food groups, nutrients intake, cardio-metabolic biomarkers, and liver enzymes in successful and unsuccessful weight loss maintainers. Obes Med 2019;16:100147.
     
186. Poulimeneas D, Anastasiou CA, Santos I, Hill JO, Panagiotakos DB, Yannakoulia M. Exploring the relationship between the Mediterranean diet and weight loss maintenance: the MedWeight study. Br J Nutr 2020;124:874-80.
     
187. Sedin A, Olsson ML, Cloetens L. The effects of 2-year consumption of a new Nordic diet on weight loss maintenance in subjects with obesity: a randomised controlled intervention study. Obes Rev 2020;21(Suppl 1):EP201.
188. Butryn ML, Godfrey KM, Call CC, Forman EM, Zhang F, Volpe SL. Promotion of physical activity during weight loss maintenance: a randomized controlled trial. Health Psychol 2021;40:178-87.
     
189. Iłowiecka K, Glibowski P, Skrzypek M, Styk W. The longterm dietitian and psychological support of obese patients who have reduced their weight allows them to maintain the effects. Nutrients 2021;13:2020.
     
190. Lawlor ER, Hughes CA, Duschinsky R, Pountain GD, Hill AJ, Griffin SJ, et al. Cognitive and behavioural strategies employed to overcome "lapses" and prevent "relapse" among weight-loss maintainers and regainers: a qualitative study. Clin Obes 2020;10:e12395.
     
191. Nguyen B, Shrewsbury VA, O'Connor J, Steinbeck KS, Hill AJ, Shah S, et al. Two-year outcomes of an adjunctive telephone coaching and electronic contact intervention for adolescent weight-loss maintenance: the Loozit randomized controlled trial. Int J Obes (Lond) 2013;37:468-72.
     
192. Fawcett E, Van Velthoven MH, Meinert E. Long-term weight management using wearable technology in overweight and obese adults: systematic review. JMIR Mhealth Uhealth 2020;8:e13461.
     
193. Kurscheid T, Redaelli M, Heinen A, Hahmann P, Behle K, Froboese I. App-controlled feedback devices can support sustainability of weight loss: multicentre QUANT-study shows additional weight loss and gain of QoL via multiple feedbackdevices in OPTIFAST 52-program. Z Psychosom Med Psychother 2019;65:224-38.
     
194. Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale P, et al. Liraglutide provides weight maintenance and additional weight loss after low calorie diet-induced weight loss in obese subjects without diabetes: the SCALE maintenance study. Diabetes 2011;60(Suppl 1):A502.
195. El Ansari W, Elhag W. Weight regain and insufficient weight loss after bariatric surgery: definitions, prevalence, mechanisms, predictors, prevention and management strategies, and knowledge gaps: a scoping review. Obes Surg 2021;31:1755-66.
     
196. Ard JD, Beavers DP, Hale E, Miller G, McNatt S, Fernandez A. Use of phentermine-topiramate extended release in combination with sleeve gastrectomy in patients with BMI 50 kg/m2 or more. Surg Obes Relat Dis 2019;15:1039-43.
     
197. Horber FF, Steffen R. Reversal of long-term weight regain after Roux-en-Y gastric bypass using liraglutide or surgical revision: a prospective study. Obes Surg 2021;31:93-100.
     
198. Miras AD, Pérez-Pevida B, Aldhwayan M, Kamocka A, Mc-Glone ER, Al-Najim W, et al. Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 2019;7:549-59.
     
199. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
     
200. Nam GE, Park HS. Perspective on diagnostic criteria for obesity and abdominal obesity in Korean adults. J Obes Metab Syndr 2018;27:134-42.
     
201. Van Gaal LF, Wauters MA, De Leeuw IH. The beneficial effects of modest weight loss on cardiovascular risk factors. Int J Obes Relat Metab Disord 1997;21 Suppl 1:S5-9.
202. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
     
203. Diabetes Prevention Program Outcomes Study Research Group; Orchard TJ, Temprosa M, Barrett-Connor E, Fowler SE, Goldberg RB, et al. Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med 2013;30:46-55.
     
204. Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med 2012;10:138.
     
205. Tortosa A, Bes-Rastrollo M, Sanchez-Villegas A, Basterra-Gortari FJ, Nuñez-Cordoba JM, Martinez-Gonzalez MA. Mediterranean diet inversely associated with the incidence of metabolic syndrome: the SUN prospective cohort. Diabetes Care 2007;30:2957-9.
     
206. Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, et al. Glycemic index: overview of implications in health and disease. Am J Clin Nutr 2002;76:266S-73S.
     
207. Lien LF, Brown AJ, Ard JD, Loria C, Erlinger TP, Feldstein AC, et al. Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension 2007;50:609-16.
     
208. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, et al. Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007;116:1081-93.
     
209. Johnson JL, Slentz CA, Houmard JA, Samsa GP, Duscha BD, Aiken LB, et al. Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise). Am J Cardiol 2007;100:1759-66.
     
210. Matikainen N, Taskinen MR. Management of dyslipidemias in the presence of the metabolic syndrome or type 2 diabetes. Curr Cardiol Rep 2012;14:721-31.
     
211. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007;369:201-7.
     
212. Rao G, Burke LE, Spring BJ, Ewing LJ, Turk M, Lichtenstein AH, et al. New and emerging weight management strategies for busy ambulatory settings: a scientific statement from the American Heart Association endorsed by the Society of Behavioral Medicine. Circulation 2011;124:1182-203.
     
213. Raaijmakers LC, Pouwels S, Berghuis KA, Nienhuijs SW. Technology-based interventions in the treatment of overweight and obesity: a systematic review. Appetite 2015;95:138-51.
     
214. Afshin A, Babalola D, Mclean M, Yu Z, Ma W, Chen CY, et al. Information technology and lifestyle: a systematic evaluation of internet and mobile interventions for improving diet, physical activity, obesity, tobacco, and alcohol use. J Am Heart Assoc 2016;5:e003058.
     
215. Kim M, Kim Y, Go Y, Lee S, Na M, Lee Y, et al. Multidimensional cognitive behavioral therapy for obesity applied by psychologists using a digital platform: open-label randomized controlled trial. JMIR Mhealth Uhealth 2020;8:e14817.
     
216. Hinchliffe N, Capehorn MS, Bewick M, Feenie J. The potential role of digital health in obesity care. Adv Ther 2022;39:4397-412.